Multicentric Randomized Study of Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Trial Profile

Multicentric Randomized Study of Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Suspended
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Thrombosis
  • Focus Therapeutic Use
  • Acronyms RIPORT
  • Most Recent Events

    • 21 Apr 2016 Status changed from recruiting to suspended.
    • 24 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 23 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top